A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently specific mRNA sequences will produce proteins, both generally and in various ...
A graduate student from the Massachusetts Institute of Technology (MIT) is poised to commercialize a new technology for improving the cost-effectiveness of mRNA manufacture. Nathan Stover is working ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results